Search research articles
Contact Us
Filters
Showing results (31-40 of 76) with videos related to
Page
of 8
Sort By:
Medicine
|
June 23, 2017
Prognostic impact of Ki-67 in patients with gastric cancer-the importance of depth of invasion and histologic differentiation
Gyung Hyuck Ko, Se-Il Go, Won Sup Lee, et al.
Current Issues in Molecular Biology
|
June 20, 2022
Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, et al.
Oncotarget
|
April 8, 2017
A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one
Se-Il Go, Mi Jung Park, Haa-Na Song, et al.
Cancer Research and Treatment
|
March 28, 2019
The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, et al.
Clinical Lung Cancer
|
December 21, 2013
Clinical significance of downstaging in patients with limited-disease small-cell lung cancer
Se-Il Go, Bhumsuk Keam, Tae Min Kim, et al.
Cancer Chemotherapy and Pharmacology
|
December 9, 2016
The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas
Young Saing Kim, Sung Yong Oh, Se-Il Go, et al.
British Journal of Cancer
|
February 13, 2019
Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer
Seok-Hyun Kim, Se-Il Go, Dae Hyun Song, et al.
BMC Cancer
|
November 6, 2023
Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma
Se-Il Go, Bong-Hoi Choi, Mi Jung Park, et al.
Cancer Research and Treatment
|
March 18, 2015
CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
April 23, 2016
Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Se-Il Go, Mi Jung Park, Haa-Na Song, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 76) with videos related to
Sort By:
Page
of 8
Medicine
|
June 23, 2017
Prognostic impact of Ki-67 in patients with gastric cancer-the importance of depth of invasion and histologic differentiation
Gyung Hyuck Ko, Se-Il Go, Won Sup Lee, et al.
Current Issues in Molecular Biology
|
June 20, 2022
Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, et al.
Oncotarget
|
April 8, 2017
A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one
Se-Il Go, Mi Jung Park, Haa-Na Song, et al.
Cancer Research and Treatment
|
March 28, 2019
The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, et al.
Clinical Lung Cancer
|
December 21, 2013
Clinical significance of downstaging in patients with limited-disease small-cell lung cancer
Se-Il Go, Bhumsuk Keam, Tae Min Kim, et al.
Cancer Chemotherapy and Pharmacology
|
December 9, 2016
The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas
Young Saing Kim, Sung Yong Oh, Se-Il Go, et al.
British Journal of Cancer
|
February 13, 2019
Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer
Seok-Hyun Kim, Se-Il Go, Dae Hyun Song, et al.
BMC Cancer
|
November 6, 2023
Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma
Se-Il Go, Bong-Hoi Choi, Mi Jung Park, et al.
Cancer Research and Treatment
|
March 18, 2015
CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer
Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
April 23, 2016
Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
Se-Il Go, Mi Jung Park, Haa-Na Song, et al.
Page
of 8